Total Funding
76
65
Total FundingNon-equity Assistance raised
Growth Score
-3 pts
Heat Score
-7 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
42385
SyntheticGestalt develops machine learning models for drug discovery and software for facilitating and automating research.
Kotaro Kamiya: Chief Technology Officer & Board Member
Koki Shimada: Co-Founder, CEO, Representative Director & Board MemberPast Role: Capy Inc., Co-Founder & CTO
About the Company
SyntheticGestalt creates tools and methods for applied machine learning-based drug discovery that are aimed at streamlining and automating research in the life sciences sector. The company's synthetic biology simulation models can accurately predict the outcomes of various amino acid arrangements without having to perform time-consuming
experimental steps, helping pharmaceutical companies by automating and accelerating the drug development process. Preclinical candidates are chemical compounds discovered through research that have the potential to become new drugs for the treatment of a particular disease.
